The cardiac troponin test detects damage to the heart muscle. Troponin is a protein that appears in the blood only when the heart muscle is damaged, as in a heart attack. There are other causes of ...
ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today announced that CBSET, a not-for-profit preclinical research institute dedicated to biomedical research ...
Compliance 360 deg results presented by Dr. Raymond Dattilo show superior outcomes at six months for peripheral arterial disease patients treated with CSI's device. St. Paul, MN & San Francisco, CA ...
On the heels of STRIDE, one of the first trials to show glucagon-like peptide-1 (GLP-1) receptor agonists can help patients with PAD, a retrospective study of more than 100,000 patients provides more ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Hosted on MSN
Patients with peripheral arterial disease and Afib found to face higher risk for cardiac events
New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk ...
New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results